Cadrenal Therapeutics (CVKD) Shares Outstanding (2022 - 2026)
Cadrenal Therapeutics (CVKD) reported Shares Outstanding of 2.91 million for Q2 2026, up 48.5% from 1.96 million a year earlier and up 21.0% from the prior quarter.
Powered by 
Analysis
Cadrenal Therapeutics (CVKD) Shares Outstanding (2022 - 2026) Analysis & Trends
For FY2025, Cadrenal Therapeutics posted Shares Outstanding of 1.99 million, up 63.5% from FY2024.
- Shares Outstanding has increased for three consecutive years, with a three-year compound annual growth rate of 55.9% (FY2022 to FY2025).
- By year, Shares Outstanding came in at 1.22 million in FY2024 (+35.6%), 899,510 in FY2023 (+71.0%) and 526,060 in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Shares Outstanding in data going back to Q1 2022.
- Year over year, Shares Outstanding has now increased in each of the last 14 quarters, with growth averaging 53.4% over the last eight quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding ranged from 7.6% (Q3 2024) to 91.6% (Q3 2023).
- Per Business Quant data, the three quarters before Q2 2026 came in at 2.41 million (Q1 2026), 1.99 million (Q4 2025) and 2.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.70 Mn |
| 10 | Cadrenal Therapeutics | 3.35 Mn | -9.27 Mn | - | 2.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.91 Mn |
| Mar 31, 2026 | 2.41 Mn |
| Dec 31, 2025 | 1.99 Mn |
| Sep 30, 2025 | 2.04 Mn |
| Jun 30, 2025 | 1.96 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 1.07 Mn |
| Dec 31, 2023 | 899,510.00 |
| Sep 30, 2023 | 1.03 Mn |
| Jun 30, 2023 | 781,556.00 |
| Mar 31, 2023 | 718,202.00 |
| Dec 31, 2022 | 526,060.00 |
| Sep 30, 2022 | 535,841.00 |
| Jun 30, 2022 | 514,692.00 |
| Mar 31, 2022 | 500,025.00 |
API Access
Cadrenal Therapeutics Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=CVKD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "CVKD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=CVKD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();